Sm. Gardiner et al., Depressor and regionally-selective vasodilator effects of human and rat urotensin II in conscious rats, BR J PHARM, 132(8), 2001, pp. 1625-1629
The regional haemodynamic effects of rat or human urotensin II (U-II) 3, 30
, 300 and 3000 pmol kg(-1), i.v.) were assessed in separate groups of consc
ious, unrestrained, male, Sprague-Dawley rats (n=8 in each). Rat and human
U-II had similar effects. At a dose of 3 pmol kg(-1), neither peptide had a
ny significant action, while at a dose of 30 pmol kg(-1), there was a trans
ient mesenteric vasodilatation (significant only for rat U-II). At doses of
300 and 3000 pmol kg(-1), there were dose-dependent tachycardias, and mese
nteric and hindquarters hyperaemic vasodilatations. Thus, in conscious rats
, the predominant cardiovascular action of rat and human U-II is vasodilata
tion. This is in contrast to recent findings with human U-II in non-human p
rimates, but is consistent with effects on human isolated resistance vessel
s.